You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Continue
COVID-19 Resource Center

News

Getinge Interim Report January-June 2016

Press releaseGothenburg 2016.07.14

Getinge Interim Report January-June 2016

Second quarter of 2016 in brief  

  •  Order intake: -0.7% to SEK 7,460 M (7,516). The order intake grew organically by 3.0%.
  •  Net sales: -3.5% to SEK 6,927 M (7,181). Net sales fell organically by 0.3%.
  •  Gross margin: 45.7% (46.4). Affected negatively by currencies.
  •  EBITA*: +10.2% to SEK 788 M (715).
  •  Restructuring and integration costs: SEK 133 M (86).
  •  Profit before tax: +28.0% to SEK 311 M (243).
  •  Earnings per share: SEK 0.93 (0.71).
  •  Good cost control: Administrative and selling expenses declined by 8.4%.
  •  New President of Acute Care Therapies: Jens Viebke
  •  FDA update: Getinge is still awaiting a decision by the FDA regarding the remediation plan in Hechingen.
  •  Strengthened customer offering: Launches include a new mobile operating table.
January-June 2016 in brief 
  •  Order intake: -2.2% to SEK 14,384 M (14,708). The order intake grew organically by 0.5%.
  •  Net sales: -4.2% to SEK 13,304 M (13,893). Net sales fell organically by 1.7%.
  •  Gross margin: 46.4% (46.6).
  •  EBITA*: -1.7% to SEK 1,408 M (1,432).
  •  Restructuring and integration costs: SEK 260 M (270).
  •  Profit before tax: +20.6% to SEK 468 M (388).
  •  Earnings per share: SEK 1.39 (1.09).
  •  The transformation and efficiency-enhancement program was initiated and a Group-wide sales organization was established.
Financial summary  
MSEK Q2 2016 Q2 2015 Change % Jan-Jun 2016 Jan-Jun 2015 Change % Rolling 12M FY 2015
Order intake 7 460  7 516 -0.7% 14 384 14 708 -2.2% 30 107 30 431
Net sales 6 927  7 181 -3.5% 13 304 13 893 -4.2% 29 646 30 235
Gross Profit 3 167  3 331 -4.9% 6 178 6 473 -4.6% 13 868 14 163
Gross margin 45.7%  46.4% -0.7% 46.4% 46.6% -0.2% 46.8% 46.8%
EBITA* 788  715 10.2%  1 408  1 432 -1.7%  4 155  4 179
EBITA margin* 11.4%  10.0% 1.4%  10.6%  10.3% 0.3%  14.0%  13.8%
Operating profit 473  428 10.5% 789 762 3.5% 2 756 2 729
Profit before tax 311  243 28.0% 468 388 20.6% 2 077 1 997
Net profit 227  177 28.2% 342 283 20.8% 1 516 1 457
Earnings per share 0.93       0.71     31.0%          1.39   1.09   27.5%                6.13   5.83
Cash flow from operations 463                 598 -22.6% 1 163                               1 252 -7.1%              3 369 3 458

* before restructuring, acquisition and integration cost
                       

Files

Share: